id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
APHIS-2020-0054-0142,APHIS,APHIS-2020-0054,Petition to Manufacture Foot-and-Mouth Disease Vaccine in the United States,Notice,Extension of Comment Period,2020-12-02T05:00:00Z,2020,12,2020-12-02T05:00:00Z,2021-01-05T04:59:59Z,2021-01-05T02:03:37Z,2020-26560,0,0,09000064849814c7
APHIS-2020-0054-0143,APHIS,APHIS-2020-0054,"APHIS Risk Assessment Summary of the FMD-LL3B3D A24 Cruzeiro Vaccine, October 2020",Supporting & Related Material,Risk Assessment,2020-12-02T05:00:00Z,2020,12,,,2020-12-02T13:24:27Z,,0,0,090000648493e588
APHIS-2020-0054-0002,APHIS,APHIS-2020-0054,"Position Statement on Manufacturing FMD LL3B3D Platform Viruses in the United States: Zoetis, Inc.",Supporting & Related Material,Petition,2020-07-14T04:00:00Z,2020,7,,,2020-07-14T12:22:16Z,,0,0,09000064846cae27
APHIS-2020-0054-0001,APHIS,APHIS-2020-0054,Petition to Manufacture Foot-and-Mouth Disease Vaccine  in the United States,Notice,Notice of Receipt of Petition,2020-07-14T04:00:00Z,2020,7,2020-07-14T04:00:00Z,2020-09-15T03:59:59Z,2020-09-16T01:01:17Z,2020-15031,0,0,0900006484753036